$ALT
Altimmune Inc

2012 Q2 Form 10-Q Financial Statement

#000114420412027422 Filed on May 10, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q1
Revenue $6.320M $6.150M $6.340M
YoY Change -1.71% -3.0% 103.21%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.780M $2.950M $4.940M
YoY Change -18.48% -40.28% -7.32%
% of Gross Profit
Research & Development $4.919M $4.705M $5.820M
YoY Change -17.8% -19.16% 17.58%
% of Gross Profit
Depreciation & Amortization $70.00K $90.00K $120.0K
YoY Change -36.36% -25.0% -52.0%
% of Gross Profit
Operating Expenses $7.775M $7.740M $10.88M
YoY Change -18.24% -28.85% 3.4%
Operating Profit -$1.458M -$1.591M -$4.540M
YoY Change -52.68% -64.96%
Interest Expense $111.4K $3.028K $15.44K
YoY Change 633.89% -80.38% -102.27%
% of Operating Profit
Other Income/Expense, Net $717.8K -$938.8K $2.464M
YoY Change 11.51% -138.1% 1660.2%
Pretax Income -$740.4K -$2.529M -$2.076M
YoY Change -69.63% 21.86% -73.86%
Income Tax $16.13K $150.4K $0.00
% Of Pretax Income
Net Earnings -$756.5K -$2.680M -$2.076M
YoY Change -68.96% 29.11% -73.86%
Net Earnings / Revenue -11.97% -43.58% -32.74%
Basic Earnings Per Share -$0.02 -$0.06 -$0.04
Diluted Earnings Per Share -$0.02 -$0.06 -$0.04
COMMON SHARES
Basic Shares Outstanding 48.33M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.80M $15.30M $9.700M
YoY Change -16.9% 57.73% 1285.71%
Cash & Equivalents $11.78M $15.30M $9.708M
Short-Term Investments
Other Short-Term Assets $700.0K $800.0K $1.800M
YoY Change -50.0% -55.56% 125.0%
Inventory
Prepaid Expenses
Receivables $8.200M $5.400M $8.900M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $20.68M $21.53M $20.40M
YoY Change -9.68% 5.53% 10.87%
LONG-TERM ASSETS
Property, Plant & Equipment $625.5K $702.0K $1.100M
YoY Change -37.45% -36.18% -83.08%
Goodwill $2.348M $2.348M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $150.5K $174.5K $100.0K
YoY Change 50.48% 74.53% -66.67%
Total Long-Term Assets $3.124M $3.225M $3.500M
YoY Change -8.1% -7.86% -65.35%
TOTAL ASSETS
Total Short-Term Assets $20.68M $21.53M $20.40M
Total Long-Term Assets $3.124M $3.225M $3.500M
Total Assets $23.81M $24.75M $23.90M
YoY Change -9.48% 3.57% -16.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.063M $1.411M $3.900M
YoY Change -17.49% -63.83% -35.0%
Accrued Expenses $3.100M $2.900M $2.800M
YoY Change -8.82% 3.57% -66.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $857.8K $0.00
YoY Change
Long-Term Debt Due $454.5K $195.4K
YoY Change
Total Short-Term Liabilities $5.659M $5.314M $6.700M
YoY Change -4.08% -20.69% -53.47%
LONG-TERM LIABILITIES
Long-Term Debt $1.984M $2.235M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $564.9K $556.0K $6.300M
YoY Change -91.03% -91.17% 530.0%
Total Long-Term Liabilities $2.548M $2.791M $6.300M
YoY Change -59.55% -55.7% -67.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.659M $5.314M $6.700M
Total Long-Term Liabilities $2.548M $2.791M $6.300M
Total Liabilities $10.26M $10.98M $13.00M
YoY Change -15.88% -15.52% -61.42%
SHAREHOLDERS EQUITY
Retained Earnings -$197.1M -$196.4M
YoY Change
Common Stock $209.7M $209.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.55M $13.77M $10.80M
YoY Change
Total Liabilities & Shareholders Equity $23.81M $24.75M $23.90M
YoY Change -9.48% 3.57% -16.14%

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q1
OPERATING ACTIVITIES
Net Income -$756.5K -$2.680M -$2.076M
YoY Change -68.96% 29.11% -73.86%
Depreciation, Depletion And Amortization $70.00K $90.00K $120.0K
YoY Change -36.36% -25.0% -52.0%
Cash From Operating Activities -$2.700M $791.4K -$2.087M
YoY Change 107.69% -137.91% -52.35%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $70.00K $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $67.40K $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $82.48K
YoY Change -100.0% -374.93%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -810.0K $3.205M 12.76K
YoY Change -113.99% 25014.53% -109.82%
NET CHANGE
Cash From Operating Activities -2.700M $791.4K -2.087M
Cash From Investing Activities 0.000 $67.40K 0.000
Cash From Financing Activities -810.0K $3.205M 12.76K
Net Change In Cash -3.510M $4.063M -2.075M
YoY Change -178.7% -295.87% 24.97%
FREE CASH FLOW
Cash From Operating Activities -$2.700M $791.4K -$2.087M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$2.700M $791.4K -$2.087M
YoY Change 112.6% -137.91% -49.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48334510 shares
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9708249
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
802080
CY2012Q1 us-gaap Goodwill
Goodwill
2348453
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
209111489
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174525
CY2012Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
857808
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
13770867
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
1023891
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
1146380
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48314510 shares
CY2012Q1 us-gaap Liabilities
Liabilities
10982817
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1410516
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
555983
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196369345
CY2012Q1 us-gaap Assets
Assets
24753684
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22803509
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11236771
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48236172 shares
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4615342
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
4824
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2011Q4 us-gaap Assets Current
AssetsCurrent
19613006
CY2011Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1886652
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
788666
CY2011Q4 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3169642
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4539935
CY2011Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
745895
CY2012Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
4276075
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24753684
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15304189
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48314510 shares
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5313808
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
4832
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q1 us-gaap Assets Current
AssetsCurrent
21528724
CY2012Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2878314
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
701982
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
195412
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2234712
CY2012Q1 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2850072
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11785327
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
830585
CY2011Q4 us-gaap Goodwill
Goodwill
2348453
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
208525917
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53384
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
15851806
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
1010522
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
4424442
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48236172 shares
CY2011Q4 us-gaap Liabilities
Liabilities
6951703
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1445700
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
449709
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193689457
CY2011Q4 us-gaap Assets
Assets
22803509
CY2011Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3021208
CY2011Q1 us-gaap Interest Paid
InterestPaid
15435
CY2011Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46276874 shares
CY2011Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
82478
CY2011Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11906
CY2011Q1 us-gaap Contracts Revenue
ContractsRevenue
6337722
CY2011Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2098720
CY2011Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-69718
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
710625
CY2011Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2488465
CY2011Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
2478570
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2011Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
117629
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2087274
CY2011Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3154
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2077078
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4939654
CY2011Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-667991
CY2011Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2977613
CY2011Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-23063
CY2011Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2075657
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5820374
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12760
CY2011Q1 us-gaap Operating Expenses
OperatingExpenses
10877657
CY2011Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-264335
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-2075657
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2464278
CY2011Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2564
CY2011Q1 us-gaap Interest Expense
InterestExpense
15435
CY2012Q1 dei Trading Symbol
TradingSymbol
PIP
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
PHARMATHENE, INC
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001326190
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1590696
CY2012Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
220234
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-35280
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52915
CY2012Q1 us-gaap Contracts Revenue
ContractsRevenue
6149052
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2666519
CY2012Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-32960
CY2012Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
857808
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
548664
CY2012Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
67400
CY2012Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-991662
CY2012Q1 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
1254867
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
85910
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
791370
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
67400
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2988
CY2012Q1 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
100000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4067418
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2948481
CY2012Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2500000
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-137362
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
150405
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4034
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3278062
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13369
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2529483
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4705357
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3204614
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
7739748
CY2012Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-364034
CY2012Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
66626
CY2012Q1 us-gaap Interest Paid
InterestPaid
3028
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48269894 shares
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
150405
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-2679888
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-938787
CY2012Q1 us-gaap Interest Expense
InterestExpense
3028
CY2012Q1 pip Supplemental Warrant Issued In Connection With Long Term Debt
SupplementalWarrantIssuedInConnectionWithLongTermDebt
69876

Files In Submission

Name View Source Status
0001144204-12-027422-index-headers.html Edgar Link pending
0001144204-12-027422-index.html Edgar Link pending
0001144204-12-027422.txt Edgar Link pending
0001144204-12-027422-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
pip-20120331.xml Edgar Link completed
pip-20120331.xsd Edgar Link pending
pip-20120331_cal.xml Edgar Link unprocessable
pip-20120331_def.xml Edgar Link unprocessable
pip-20120331_lab.xml Edgar Link unprocessable
pip-20120331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v310737_10q.htm Edgar Link pending
v310737_ex31-1.htm Edgar Link pending
v310737_ex31-2.htm Edgar Link pending
v310737_ex32-1.htm Edgar Link pending
v310737_ex32-2.htm Edgar Link pending